Business Wire

BREGAL-MILESTONE

15.5.2024 06:01:36 CEST | Business Wire | Press release

Share
Allshares Solidifies Nordic Leadership With the Acquisition of Aktieinvest Incentives

Bregal Milestone, a leading European technology and software private equity firm, is pleased to announce the acquisition of Aktieinvest Incentives by its portfolio company, Allshares, a pioneering compensation and long-term incentive software and services provider. Following Allshares’ recent acquisition of Novare Pay, the strategic addition of Aktieinvest Incentives further establishes the company at the forefront of providing comprehensive compensation and incentive solutions in Sweden.

Aktieinvest Incentives is a leading provider of share plan and equity incentive administration to business customers in Sweden. Following the acquisition, Aktieinvest Incentives will fully integrate with Allshares’ state-of-the-art equity plan administration platform. Current Aktieinvest Incentives customers can expect uninterrupted service and will benefit from Allshares’ exceptional client support and end-to-end solutions, including expanded offerings like tax services and IFRS reporting.

In a statement from Louise Hagsten, CEO of Aktieinvest Incentives, the decision to integrate with Allshares was underscored by its unmatched holistic software and services offering. "Our partnership with Allshares heralds a new era of innovation and client-centricity for Aktieinvest Incentives customers. We were drawn to Allshares' commitment to excellence and their robust equity plan administration product suite which includes tax and IFRS reporting capabilities. We are confident that joining forces with Allshares will translate to an enhanced digital participant experience for Aktieinvest Incentives’ customers."

Erika Andersson, former CEO of Novare Pay and recently appointed CEO of Allshares Sweden, stated, “The reception of Allshares by Novare Pay customers and the broader Swedish market has been overwhelmingly positive. I am confident that Aktieinvest Incentives’ customers will have a similar experience, thanks to Allshares’ customer-centric and innovative approach to compensation solutions. The Allshares proposition stands out in the market, and I am eager to maintain our longstanding relationship with Aktieinvest Incentives’ customers. With Allshares, we can offer an enhanced equity plan administration proposition, further improving our ability to serve customers effectively.”

Pertti Helaniemi, CEO of Allshares Finland, highlighted the continuity and seamless experience that customers can expect from the addition of Aktieinvest Incentives to the Allshares ecosystem. "At Allshares, we are dedicated to maintaining high standards of service and innovation. In addition to Allshares’ comprehensive equity plan administration platform, our Pay Incentives, Pay Governance and Pay Analytics service offerings mean clients can expect a seamless one-stop experience for all their compensation needs."

John Hales, Managing Director at Bregal Milestone, reiterated the company's vision and the integral role that Aktieinvest Incentives plays in achieving it. "At Allshares, the vision is to deliver leading compensation solutions that drive high performance for both private and publicly listed customers throughout Europe. The acquisition of Aktieinvest Incentives is a testament to our commitment to this vision, as it strengthens our position as a leader in the Nordic region and reinforces our ability to deliver exceptional value to leading companies. We are thrilled to welcome Aktieinvest Incentives to the Allshares family and look forward to leveraging our combined strengths to deliver distinctive compensation solutions."

Terms of the transaction were not disclosed and are subject to customary closing conditions.

About Bregal Milestone

Bregal Milestone is a leading European software and technology private equity firm with c.€1.3 billion of capital raised since inception. The firm provides growth capital and operational support to build market-leading technology companies. Bregal Milestone is part of Bregal Investments, a leading global investment platform with assets under management of over €18 billion. Bregal Milestone was recognised by GrowthCap as one of the Top Growth Equity Firms of 2023. For more information, visit www.bregalmilestone.com or follow us on LinkedIn.

About Allshares

Allshares is a pioneering provider of compensation and incentive solutions in Europe. Trusted by leading multinational enterprises, Allshares will now serve approximately 900 clients in more than 60 countries with an end-to-end digital turnkey solution for equity plan management. Companies and participants can use its proprietary software and services to administer share plans in full compliance with relevant regulations, legal, and tax frameworks, as well as deliver seamless and automated IFRS reporting of share plans to companies. For more information, visit www.allshares.com.

About Aktieinvest

Aktieinvest Incentives is a part of Aktieinvest. Aktieinvest, among Sweden's oldest online brokers, boasts a 50-year legacy and 60,000 customers. Aktieinvest offers monthly share savings, dividend reinvestment, and handles corporate events, essentially simplifying stock investment. With a workforce of around 40, and a customer-centric approach, Aktieinvest has consistently sought to modernize and enhance its offerings, ensuring that clients can seamlessly save and invest in both Swedish and foreign stocks, funds, and ETFs. Since June 2023, Aktieinvest has been under the ownership of Söderberg & Partners, a prominent financial advisor and intermediary in the Nordic region. For more information, visit www.allshares.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240514298200/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release

Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye